[{"id":"e163f92a-4f3b-4c62-bf4a-7bb7cbdc38bf","acronym":"","url":"https://clinicaltrials.gov/study/NCT05010694","created_at":"2021-08-18T14:53:30.962Z","updated_at":"2024-07-02T16:35:01.172Z","phase":"Phase 1","brief_title":"Dose Finding Study of GH35 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT05010694","lead_sponsor":"Suzhou Genhouse Bio Co., Ltd.","biomarkers":" KRAS","pipe":" | ","alterations":" KRAS mutation","tags":["KRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GH35"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 09/27/2021","start_date":" 09/27/2021","primary_txt":" Primary completion: 03/22/2023","primary_completion_date":" 03/22/2023","study_txt":" Completion: 12/12/2025","study_completion_date":" 12/12/2025","last_update_posted":"2024-05-24"}]